Skip to main content
SpringerLink
Log in

A Randomized, Double-Blind, Placebo-Controlled Trial of Intravenous Acetaminophen on Hospital Length of Stay in Obese Individuals Undergoing Sleeve Gastrectomy

  • Original Contributions
  • Published:
Obesity Surgery Aims and scope Submit manuscript

Abstract

Background

Retrospective studies indicate that acetaminophen iv administration reduces hospital length of stay (LoS) and opiate consumption in patients undergoing bariatric surgery.

Objective

This study sought to determine whether using acetaminophen iv in morbidly obese subjects undergoing sleeve gastrectomy decreased LoS and total hospital charges as compared to patients receiving saline placebo.

Setting

Single-center university hospital

Methods

Using a randomized, double-blind, placebo-controlled design, subjects were assigned to receive either acetaminophen iv (group A) or saline placebo iv (group P). Data were collected between Jan 1 and Dec 31, 2016. Group A received acetaminophen every 6 h for a total of four doses. The first dose was administered following the induction of general anesthesia; group P received saline iv on the same schedule. Anesthetic management and prophylactic antiemetic regimen were standardized in all subjects. Postoperative pain management consisted of hydromorphone via patient-controlled infusion pump. Primary outcomes include hospital LoS and associated hospital costs. Secondary outcomes include patient satisfaction and postoperative nausea and pain scores.

Results

Subject demographics (n = 127) and intraoperative management were similar in the two groups. Across all subjects, median hospital LoS in group A (n = 63) was 1.87 vs. 1.97 days in group P (n = 64) (p = 0.03, Wilcoxon rank-sum test). Postoperatively, daily quality-of-recovery (QoR-15) scores, narcotic consumption, and the use of rescue antiemetics were not significantly different between groups. Median hospital costs were as follows: group A, $12,885 vs. group P, $12,977 (n = 64).

Conclusions

Acetaminophen iv may reduce hospital LoS in subjects undergoing sleeve gastrectomy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Gastrointestinal surgery for severe obesity: National Institutes of Health Consensus Development Conference Statement. Am J Clin Nutr. 1992;55(2 Suppl):615S–9S.

  2. Hruby A, Hu FB. The epidemiology of obesity: a big picture. PharmacoEconomics. 2015;33(7):673–89.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Chang SH, Pollack LM, Colditz GA. Life years lost associated with obesity-related diseases for U.S. Non-smoking adults. PLoS One. 2013;8(6):e66550.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  4. Flegal KM, Graubard BI, Williamson DF, et al. Cause-specific excess deaths associated with underweight, overweight, and obesity. JAMA. 2007;298(17):2028–37.

    Article  PubMed  CAS  Google Scholar 

  5. Puzziferri N, Roshek 3rd TB, Mayo HG, et al. Long-term follow-up after bariatric surgery: a systematic review. JAMA. 2014;312(9):934–42.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  6. Chang SH, Stoll CR, Song J, et al. The effectiveness and risks of bariatric surgery: an updated systematic review and meta-analysis, 2003-2012. JAMA Surg. 2014;149(3):275–87.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Courcoulas AP, Christian NJ, Belle SH, et al. Weight change and health outcomes at 3 years after bariatric surgery among individuals with severe obesity. JAMA. 2013;310(22):2416–25.

    PubMed  PubMed Central  CAS  Google Scholar 

  8. Courcoulas AP, Goodpaster BH, Eagleton JK, et al. Surgical vs medical treatments for type 2 diabetes mellitus: a randomized clinical trial. JAMA Surg. 2014;149(7):707–15.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Arterburn DE, Olsen MK, Smith VA, et al. Association between bariatric surgery and long-term survival. JAMA. 2015;313(1):62–70.

    Article  PubMed  CAS  Google Scholar 

  10. Brolin RE. Bariatric surgery and long-term control of morbid obesity. JAMA. 2002;288(22):2793–6.

    Article  PubMed  Google Scholar 

  11. Våge V, Sande VA, Mellgren G, et al. Changes in obesity-related diseases and biochemical variables after laparoscopic sleeve gastrectomy: a two-year follow-up study. BMC Surg. 2014;14:8.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  12. van Rutte PW, Smulders JF, de Zoete JP, et al. Outcome of sleeve gastrectomy as a primary bariatric procedure. Br J Surg. 2014;101(6):661–8.

    Article  PubMed  Google Scholar 

  13. Sieber P, Gass M, Kern B, et al. Five-year results of laparoscopic sleeve gastrectomy. Surg Obes Relat Dis. 2014;10(2):243–9.

    Article  PubMed  Google Scholar 

  14. Ponce J, DeMaria EJ, Nguyen NT, et al. American Society for Metabolic and Bariatric Surgery estimation of bariatric surgery procedures in 2015 and surgeon workforce in the United States. Surg Obes Relat Dis. 2016;12(9):1637–9.

    Article  PubMed  Google Scholar 

  15. Benevides ML, Oliveira SS, de Aguilar-Nascimento JE. The combination of haloperidol, dexamethasone, and ondansetron for prevention of postoperative nausea and vomiting in laparoscopic sleeve gastrectomy: a randomized double-blind trial. Obes Surg. 2013;23(9):1389–96.

    Article  PubMed  Google Scholar 

  16. Afaneh C, Costa R, Pomp A, et al. A prospective randomized controlled trial assessing the efficacy of omentopexy during laparoscopic sleeve gastrectomy in reducing postoperative gastrointestinal symptoms. Surg Endosc. 2015;29(1):41–7.

    Article  PubMed  Google Scholar 

  17. Mendes MN, Monteiro Rde S, Martins FA. Prophylaxis of postoperative nausea and vomiting in morbidly obese patients undergoing laparoscopic gastroplasties: a comparative study among three methods. Rev Bras Anestesiol. 2009;59(5):570–6.

    PubMed  Google Scholar 

  18. Gan TJ, Diemunsch P, Habib AS, et al. Consensus guidelines for the management of postoperative nausea and vomiting. Anesth Analg. 2014;118(1):85–113.

    Article  PubMed  Google Scholar 

  19. Eberhart LH, Mauch M, Morin AM, et al. Impact of a multimodal anti-emetic prophylaxis on patient satisfaction in high-risk patients for postoperative nausea and vomiting. Anaesthesia. 2002;57(10):1022–7.

    Article  PubMed  CAS  Google Scholar 

  20. Pan PH, Lee SC, Harris LC. Antiemetic prophylaxis for postdischarge nausea and vomiting and impact on functional quality of living during recovery in patients with high emetic risks: a prospective, randomized, double-blind comparison of two prophylactic antiemetic regimens. Anesth Analg. 2008;107(2):429–38.

    Article  PubMed  CAS  Google Scholar 

  21. Habib AS, Chen YT, Taguchi A, et al. Postoperative nausea and vomiting following inpatient surgeries in a teaching hospital: a retrospective database analysis. Curr Med Res Opin. 2006;22(6):1093–9.

    Article  PubMed  Google Scholar 

  22. DiIorio TM, Sharkey PF, Hewitt AM, et al. Antiemesis after total joint arthroplasty: does a single preoperative dose of aprepitant reduce nausea and vomiting? Clin Orthop Relat Res. 2010;468(9):2405–9.

    Article  PubMed  PubMed Central  Google Scholar 

  23. Pizzi LT, Toner R, Foley K, et al. Relationship between potential opioid-related adverse effects and hospital length of stay in patients receiving opioids after orthopedic surgery. Pharmacotherapy. 2012;32(6):502–14.

    Article  PubMed  CAS  Google Scholar 

  24. Dzwonczyk R, Weaver TE, Puente EG, et al. Postoperative nausea and vomiting prophylaxis from an economic point of view. Am J Ther. 2012;19(1):11–5.

    Article  PubMed  Google Scholar 

  25. De Oliveira Jr GS, Castro-Alves LJ, RJ MC. Single-dose systemic acetaminophen to prevent postoperative pain: a meta-analysis of randomized controlled trials. Clin J Pain. 2015;31(1):86–93.

    Article  PubMed  Google Scholar 

  26. Apfel CC, Turan A, Souza K, et al. Intravenous acetaminophen reduces postoperative nausea and vomiting: a systematic review and meta-analysis. Pain. 2013;154(5):677–89.

    Article  PubMed  CAS  Google Scholar 

  27. Song K, Melroy MJ, Whipple OC. Optimizing multimodal analgesia with intravenous acetaminophen and opioids in postoperative bariatric patients. Pharmacotherapy. 2014;34(Suppl 1):14S–21S.

    Article  PubMed  CAS  Google Scholar 

  28. Demirovic JA, Pai AB, Pai MP. Estimation of creatinine clearance in morbidly obese patients. Am J Health Syst Pharmacy. 2009;66(7):642–8.

    Article  CAS  Google Scholar 

  29. Ogunnaike BO, Jones SB, Jones DB, et al. Anesthetic considerations for bariatric surgery. Anesth Analg. 2002;95(6):1793–805.

    Article  PubMed  Google Scholar 

  30. Chang AK, Bijur PE, Meyer RH, et al. Safety and efficacy of hydromorphone as an analgesic alternative to morphine in acute pain: a randomized clinical trial. Ann Emerg Med. 2006;48(2):164–72.

    Article  PubMed  Google Scholar 

  31. Stark PA, Myles PS, Burke JA. Development and psychometric evaluation of a postoperative quality of recovery score: the QoR-15. Anesthesiology. 2013;118(6):1332–40.

    Article  PubMed  Google Scholar 

  32. Lange M, Kia M. Efficacy of IV acetaminophen in laparoscopic roux-En-Y gastric bypass surgery patients. Surg Obes Relat Dis. 2016;12:S60.

    Article  Google Scholar 

  33. Atef A, Fawaz AA. Intravenous paracetamol is highly effective in pain treatment after tonsillectomy in adults. Eur Arch Otorhinolaryngol. 2008;265(3):351–5.

    Article  PubMed  Google Scholar 

  34. Jokela R, Ahonen J, Seitsonen E, et al. The influence of ondansetron on the analgesic effect of acetaminophen after laparoscopic hysterectomy. Clin Pharmacol Ther. 2010;87(6):672–8.

    Article  PubMed  CAS  Google Scholar 

  35. Wang S, Saha R, Shah N, et al. Effect of intravenous acetaminophen on postoperative opioid use in bariatric surgery patients. P & T. 2015;40(12):847–50.

    Google Scholar 

  36. Khorgami Z, Aminian A, Shoar S, et al. Cost of bariatric surgery and factors associated with increased cost: an analysis of national inpatient sample. Surg Obes Relat Dis. 2017;13:1284–9.

    Article  PubMed  Google Scholar 

  37. Shaffer EE, Pham A, Woldman RL, et al. Estimating the effect of intravenous acetaminophen for postoperative pain management on length of stay and inpatient hospital costs. Adv Ther. 2017;33(12):2211–28.

    Article  PubMed  CAS  Google Scholar 

  38. El Chaar M, Stoltzfus J, Claros L, et al. IV acetaminophen results in lower hospital costs and emergency room visits following bariatric surgery: a double-blind, prospective, randomized trial in a single accredited bariatric center. J Gastrointest Surg. 2016;20(4):715–24.

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

This work would not have been possible without the excellent collaboration between the Departments of Anesthesiology and Surgery. The authors wish to expressly thank the many faculty, residents, nurse anesthetists, and research aides in both the Department of Anesthesiology and Surgery for their cooperation and assistance during the course of this study. We also wish to thank Paul Christos, Dr. P.H, M.S., for constructive comments and suggestions on the manuscript.

Funding

This work was funded by Mallinckrodt Pharmaceuticals. Ms. Xian Wu, MPH, was partially supported by the following grant: Clinical and Translational Science Center at Weill Cornell Medical College (UL1-TR000457-06).

Author information

Authors and Affiliations

  1. Department of Anesthesiology, Weill Cornell Medical College, 1300 York Avenue, Room A-1050, New York, NY, 10065, USA

    Farrell E. Cooke, Jon D. Samuels, Farida Gadalla & Peter A. Goldstein

  2. Department of Surgery, Weill Cornell Medical College, New York, NY, USA

    Alfons Pomp, Cheguevara Afaneh & Gregory F. Dakin

  3. Department of Healthcare Policy and Research (Division of Biostatistics and Epidemiology), Weill Cornell Medical College, New York, NY, USA

    Xian Wu

  4. Department of Medicine, Weill Cornell Medical College, New York, NY, USA

    Peter A. Goldstein

Authors
  1. Farrell E. Cooke
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jon D. Samuels
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Alfons Pomp
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Farida Gadalla
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Xian Wu
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Cheguevara Afaneh
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Gregory F. Dakin
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Peter A. Goldstein
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

Study concept/design (JDS, AP, PAG), data acquisition (FEC, JDS, AP, FG, CA, GFD, PAG), data analysis (FEC, XW, PAG), interpretation of data (FEC, AP, FG, XW, CA, PAG), manuscript preparation (FEC, PAG), manuscript revision/editing (FEC, JDS, AP, FG, XW, CA, GFD, PAG), approval of submitted manuscript (FEC, JDS, AP, FG, XW, CA, GFD, PAG), agreement to be accountable for all aspects of the work (FEC, JDS, AP, FG, XW, CA, GFD, PAG).

Corresponding author

Correspondence to Peter A. Goldstein.

Ethics declarations

Conflict of Interest

FEC, JDS, FG, XW, CA, and GFD have no conflicts to declare. AP has served as a speaker for Medtronic, Ethicon, and W.L. Gore & Associates and has received honoraria from those companies. PAG receives additional research support from the United States Department of Defense and the Tri-Institutional Stem Cell Initiative for basic science research in areas unrelated to the work presented here.

Appendix. Quality of Recovery-15 Survey

Appendix. Quality of Recovery-15 Survey

figure a

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Cooke, F.E., Samuels, J.D., Pomp, A. et al. A Randomized, Double-Blind, Placebo-Controlled Trial of Intravenous Acetaminophen on Hospital Length of Stay in Obese Individuals Undergoing Sleeve Gastrectomy. OBES SURG 28, 2998–3006 (2018). https://doi.org/10.1007/s11695-018-3316-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11695-018-3316-7

Keywords

Search

Navigation